Somedeb Ball

1.6k total citations
99 papers, 802 citations indexed

About

Somedeb Ball is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Somedeb Ball has authored 99 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 30 papers in Oncology and 26 papers in Genetics. Recurrent topics in Somedeb Ball's work include Acute Myeloid Leukemia Research (34 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Somedeb Ball is often cited by papers focused on Acute Myeloid Leukemia Research (34 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Somedeb Ball collaborates with scholars based in United States, India and United Kingdom. Somedeb Ball's co-authors include Raktim K. Ghosh, Dhrubajyoti Bandyopadhyay, Kenneth Nugent, Wilbert S. Aronow, Anjan Gupta, Kyaw Zin Thein, Gregg C. Fonarow, Deepak L. Bhatt, Gopal Chandra Ghosh and Daniel J. Lenihan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Somedeb Ball

91 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Somedeb Ball United States 15 290 197 162 160 145 99 802
Jean‐Marie Leclerc Canada 18 320 1.1× 87 0.4× 72 0.4× 139 0.9× 167 1.2× 57 1.1k
Atul Batra India 16 309 1.1× 162 0.8× 192 1.2× 46 0.3× 103 0.7× 122 881
Nigel Baker United Kingdom 13 337 1.2× 145 0.7× 173 1.1× 470 2.9× 250 1.7× 24 1.2k
Geoffrey D. Wool United States 17 134 0.5× 69 0.4× 83 0.5× 200 1.3× 123 0.8× 53 949
Aleksandar Radujkovic Germany 18 191 0.7× 56 0.3× 78 0.5× 471 2.9× 186 1.3× 53 1.3k
Manfred Muhm Austria 19 124 0.4× 143 0.7× 262 1.6× 216 1.4× 82 0.6× 58 1.2k
Eduardo Ramacciotti United States 24 103 0.4× 549 2.8× 125 0.8× 321 2.0× 185 1.3× 82 1.4k
José Luís Poveda Spain 18 199 0.7× 40 0.2× 65 0.4× 160 1.0× 181 1.2× 90 922
Yüksel Ürün Türkiye 17 483 1.7× 51 0.3× 334 2.1× 72 0.5× 158 1.1× 136 1.1k
Katie Bechman United Kingdom 16 149 0.5× 33 0.2× 126 0.8× 184 1.1× 71 0.5× 58 993

Countries citing papers authored by Somedeb Ball

Since Specialization
Citations

This map shows the geographic impact of Somedeb Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Somedeb Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Somedeb Ball more than expected).

Fields of papers citing papers by Somedeb Ball

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Somedeb Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Somedeb Ball. The network helps show where Somedeb Ball may publish in the future.

Co-authorship network of co-authors of Somedeb Ball

This figure shows the co-authorship network connecting the top 25 collaborators of Somedeb Ball. A scholar is included among the top collaborators of Somedeb Ball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Somedeb Ball. Somedeb Ball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aguirre, Luis E., Somedeb Ball, Akriti Jain, et al.. (2025). Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease Progression. Clinical Lymphoma Myeloma & Leukemia. 25(9). 661–671.
2.
Jain, Akriti, Somedeb Ball, Onyee Chan, et al.. (2024). Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML. Annals of Hematology. 103(6). 1941–1945. 5 indexed citations
3.
Kuykendall, Andrew, Somedeb Ball, Barbara Mora, et al.. (2024). Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib. JCO Precision Oncology. 8(8). e2300593–e2300593. 3 indexed citations
4.
Jain, Akriti, Chen Wang, Somedeb Ball, et al.. (2024). Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia. Annals of Hematology. 104(1). 307–315. 2 indexed citations
5.
Aguirre, Luis E., Akriti Jain, Somedeb Ball, et al.. (2024). Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes. Clinical Lymphoma Myeloma & Leukemia. 24(7). 459–467. 2 indexed citations
6.
7.
Chan, Onyee, Kendra Sweet, Somedeb Ball, et al.. (2024). A Phase 1 Study of CPX-351 Plus Gilteritinib in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia. Blood. 144(Supplement 1). 1520–1520. 3 indexed citations
8.
Giuliano, Anna R., Barbara J. Kuter, Shari Pilon‐Thomas, et al.. (2023). Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients. Cancer Communications. 43(7). 749–764. 6 indexed citations
9.
Tinsley, Sara, Najla Al Ali, Somedeb Ball, et al.. (2023). Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes. Clinical Lymphoma Myeloma & Leukemia. 23(5). 355–359. 3 indexed citations
10.
Zhang, Yumeng, Lynn Nguyen, Chuanyi M. Lu, et al.. (2022). Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion. Clinical Lymphoma Myeloma & Leukemia. 23(3). e150–e163. 3 indexed citations
11.
Aguirre, Luis E., Akriti Jain, Somedeb Ball, et al.. (2021). Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes. Blood. 138(Supplement 1). 1494–1494. 7 indexed citations
12.
Jain, Akriti, Somedeb Ball, Elaine Tan, et al.. (2021). Responses to Sars-Cov-2 Vaccines in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia. Blood. 138(Supplement 1). 217–217. 3 indexed citations
13.
14.
Ball, Somedeb, et al.. (2020). Increased risk of cardiac conduction abnormalities with ribociclib in patients with metastatic breast cancer. Hematology/Oncology and Stem Cell Therapy. 14(3). 260–262. 8 indexed citations
15.
Ball, Somedeb, et al.. (2020). Platelets in chronic obstructive pulmonary disease: An update on pathophysiology and implications for antiplatelet therapy. Respiratory Medicine. 171. 106098–106098. 37 indexed citations
16.
17.
Ball, Somedeb, Avash Das, Wasawat Vutthikraivit, et al.. (2019). Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Lymphoma Myeloma & Leukemia. 20(2). 87–97.e5. 23 indexed citations
18.
Ball, Somedeb, Kyaw Zin Thein, Abhishek Maiti, & Kenneth Nugent. (2018). Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms. Journal of Thrombosis and Thrombolysis. 45(4). 516–528. 14 indexed citations
19.
Ghosh, Raktim K., et al.. (2016). Depression in heart failure: Intricate relationship, pathophysiology and most updated evidence of interventions from recent clinical studies. International Journal of Cardiology. 224. 170–177. 49 indexed citations
20.
Roy, Krishnendu, et al.. (2015). Characteristic OCT Pattern in Waldenstrom Macroglobulinemia. Optometry and Vision Science. 92(5). e106–e109. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Marie Leclerc Breakdown of academic impact, for papers by Atul Batra Breakdown of academic impact, for papers by Nigel Baker Breakdown of academic impact, for papers by Geoffrey D. Wool Breakdown of academic impact, for papers by Aleksandar Radujkovic Breakdown of academic impact, for papers by Manfred Muhm Breakdown of academic impact, for papers by Eduardo Ramacciotti Breakdown of academic impact, for papers by José Luís Poveda Breakdown of academic impact, for papers by Yüksel Ürün Breakdown of academic impact, for papers by Katie Bechman
Rankless by CCL
2026